- Home
- CGTX vs NAII Comparison
CGTX vs NAII Comparison
Compare CGTX & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGTX
- NAII
- Stock Information
- Founded
- CGTX 2007
- NAII 1980
- Country
- CGTX United States
- NAII United States
- Employees
- CGTX N/A
- NAII N/A
- Industry
- CGTX Biotechnology: Pharmaceutical Preparations
- NAII Medicinal Chemicals and Botanical Products
- Sector
- CGTX Health Care
- NAII Health Care
- Exchange
- CGTX Nasdaq
- NAII Nasdaq
- Market Cap
- CGTX 23.1M
- NAII 18.6M
- IPO Year
- CGTX 2021
- NAII 1987
- Fundamental
- Price
- CGTX $0.31
- NAII $3.24
- Analyst Decision
- CGTX Strong Buy
- NAII
- Analyst Count
- CGTX 5
- NAII 0
- Target Price
- CGTX $6.13
- NAII N/A
- AVG Volume (30 Days)
- CGTX 692.0K
- NAII 24.0K
- Earning Date
- CGTX 05-07-2025
- NAII 05-13-2025
- Dividend Yield
- CGTX N/A
- NAII N/A
- EPS Growth
- CGTX N/A
- NAII N/A
- EPS
- CGTX N/A
- NAII N/A
- Revenue
- CGTX N/A
- NAII $121,853,000.00
- Revenue This Year
- CGTX N/A
- NAII N/A
- Revenue Next Year
- CGTX N/A
- NAII N/A
- P/E Ratio
- CGTX N/A
- NAII N/A
- Revenue Growth
- CGTX N/A
- NAII N/A
- 52 Week Low
- CGTX $0.31
- NAII $2.57
- 52 Week High
- CGTX $2.95
- NAII $7.26
- Technical
- Relative Strength Index (RSI)
- CGTX 31.37
- NAII 55.09
- Support Level
- CGTX $0.40
- NAII $2.69
- Resistance Level
- CGTX $0.47
- NAII $3.37
- Average True Range (ATR)
- CGTX 0.03
- NAII 0.28
- MACD
- CGTX -0.01
- NAII 0.06
- Stochastic Oscillator
- CGTX 2.76
- NAII 70.24
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
About NAII Natural Alternatives International Inc.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.